GRI
GRI BIO INC近日发布了其针对特发性肺纤维化(IPF)正在进行的2a期临床研究的6周中期肺功能数据报告。该项研究旨在评估公司药物在治疗这一罕见肺部疾病方面的疗效和安全性。此次公布的中期数据为投资者和医学界提供了该药物研发进展的重要信息。
时间:2025-09-11 20:47:19 市场: 美股 综合
Dividend Component Details
时间:2025-07-15 14:35:32 市场: 综合
Gresham House Energy Storage Fund : Signed Long-Term Floor-Pricing Agreements With Two Counterparties
时间:2025-07-03 14:16:52 市场: 综合
GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“Ipf”)
时间:2025-07-01 20:45:00 市场: 美股 综合
GRI Bio Inc - Topline Results From Phase 2a Study Expected in Q3 2025
时间:2025-07-01 20:45:00 市场: 美股 综合
GRI Bio Inc - Reports Positive 6-Week Interim Safety Results for GRI-0621
时间:2025-06-26 20:01:04 市场: 美股 综合
Ground Rents Income Fund Plc - High Court Grants Grio Permission for Legal Claim Against Government
时间:2025-02-06 00:55:00 市场: 综合
Ground Rents Inc Fnd - Company Update
时间:2025-02-06 00:55:00 市场: 综合
Ground Rents Income Fund Plc - Board Assessing Possible Offers From Victoria Property Holdings
时间:2025-02-06 00:55:00 市场: 综合
AgriFORCE Growing Systems Ltd. Supercharges Growth With Robust Financing, Strategic Acquisitions, and Potential for Unprecedented Operational Excellence
时间:2025-02-04 22:32:00 市场: 美股 综合